Prognostic Value of Baseline Serum Lactate Dehydrogenase Level in Patients With Hairy Cell Leukemia
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 20 (9) , e616-e621
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behaviorBlood, 2009
- Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosisBritish Journal of Haematology, 2009
- Long remissions in hairy cell leukemia with purine analogsCancer, 2005
- Lactate: mirror and motor of tumor malignancySeminars in Radiation Oncology, 2004
- Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patientsLeukemia, 2003
- The diagnosis and treatment of hairy-cell leukaemiaBlood Reviews, 2002
- Hairy cell leukemiaCurrent Treatment Options in Oncology, 2001
- The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long‐term follow‐up studyBritish Journal of Haematology, 1997
- Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 yearsAnnals of Oncology, 1991
- New approaches for the evaluation of pulmonary toxicity: bronchoalveolar lavage fluid analysis*1Fundamental and Applied Toxicology, 1985